Richard A. Heyman - 03 Oct 2025 Form 4 Insider Report for Oric Pharmaceuticals, Inc. (ORIC)

Role
Director
Signature
/s/ Christian Kuhlen, attorney-in-fact
Issuer symbol
ORIC
Transactions as of
03 Oct 2025
Net transactions value
+$55,591
Form type
4
Filing time
03 Oct 2025, 19:18:01 UTC
Previous filing
09 Jun 2025
Next filing
06 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Heyman Richard A. Director C/O ORIC PHARMACEUTICALS, INC., 240 E. GRAND AVE., 2ND FLOOR, SOUTH SAN FRANCISCO /s/ Christian Kuhlen, attorney-in-fact 03 Oct 2025 0001584759

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORIC Common Stock Options Exercise $50,165 +31,353 +251% $1.60 43,853 03 Oct 2025 Direct
transaction ORIC Common Stock Options Exercise $5,426 +1,447 +3.3% $3.75 45,300 03 Oct 2025 Direct
holding ORIC Common Stock 216,272 03 Oct 2025 See footnote F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ORIC Stock Option (right to buy) Options Exercise $0 -13,228 -28% $0.000000 33,700 03 Oct 2025 Common Stock 13,228 $1.60 Direct F2
transaction ORIC Stock Option (right to buy) Options Exercise $0 -18,125 -100% $0.000000 0 03 Oct 2025 Common Stock 18,125 $1.60 Direct F2
transaction ORIC Stock Option (right to buy) Options Exercise $0 -1,447 -2.7% $0.000000 52,253 03 Oct 2025 Common Stock 1,447 $3.75 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held of record by RAHD Capital, LLC, and the Reporting Person has voting and investment power with respect to such shares.
F2 The shares subject to the option are fully vested and immediately exercisable.